Effects of Glimepiride and Glibenclamide on Insulin and Glucagon Secretion by the Perfused Rat Pancreas
Overview
Pharmacology
Authors
Affiliations
Glimepiride and glibenclamide act apparently in a closely comparable manner upon both insulin and glucagon release. Except for the decreased efficiency of D-glucose in suppressing glucagon release after a prior exposure of the pancreas to the hypoglycemic sulfonylureas, no evidence was obtained to suggest that a positive glucagonotropic action of the latter drugs would counteract their hypoglycemic action, as mainly attributable to stimulation of insulin release.
Vascular Effects of Avocado Seed Glycosides during Diabetes-induced Endothelial Damage.
Amadi P, Agomuo E, Adumekwe C Cardiovasc Hematol Disord Drug Targets. 2020; 20(3):202-213.
PMID: 32386502 PMC: 8226154. DOI: 10.2174/1871529X20666200510012012.
Ahangarpour A, Ali Akbari F, Fathi Moghadam H Malays J Med Sci. 2016; 23(1):15-21.
PMID: 27540321 PMC: 4975584.
Dhingra A, Chopra B, Dass R, Mittal S Int J Med Chem. 2016; 2016:3156593.
PMID: 26881075 PMC: 4737024. DOI: 10.1155/2016/3156593.
Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
Langtry H, Balfour J Drugs. 1998; 55(4):563-84.
PMID: 9561345 DOI: 10.2165/00003495-199855040-00007.
Gregorio F, Ambrosi F, Cristallini S, Filipponi P, Santeusanio F Acta Diabetol. 1996; 33(1):25-9.
PMID: 8777281 DOI: 10.1007/BF00571936.